Top Ad unit 728 × 90

Radiology News

radiology

No advantage of Sodium Bicarbonate and Acetyl cysteine in Preventing Contrast Nephropathy

Steven D. Weisbord et al in NEJM published the results of Prevention of Serious Adverse Events Following Angiography (PRESERVE) trial which was done compare intravenous sodium bicarbonate with intravenous sodium chloride and oral acetylcysteine with oral placebo for the prevention of major adverse outcomes and acute kidney injury in a large population of high-risk patients undergoing coronary or noncoronary angiography.

Among patients at high risk for renal complications who were undergoing angiography, there was no benefit of intravenous sodium bicarbonate over intravenous sodium chloride or of oral acetylcysteine over placebo for the prevention of death, need for dialysis, or persistent decline in kidney function at 90 days or for the prevention of contrast-associated acute kidney injury. 


Reference and Further Reading 

No advantage of Sodium Bicarbonate and Acetyl cysteine in Preventing Contrast Nephropathy Reviewed by Sumer Sethi on Monday, November 27, 2017 Rating: 5

No comments:

All Rights Reserved by Sumer's Radiology Blog © 2014 - 2015
Powered By Blogger,

Contact Form

Name

Email *

Message *

All contents copyrights with Sumer Sethi. Powered by Blogger.